Tang Prize Taiwan Biotech Forum



Tang Prize Taiwan Biotech Forum <The Birth of a New Generation of Drugs: mRNA>

  mRNA technology is currently the hottest topic in the biotech and medical field, receiving high attention from both the government and industry for its limitless development potential. Apart from its application in Covid vaccines, mRNA technology has great potential for revolutionary contributions to cancer therapy, gene therapy, and the prevention and treatment of other infectious diseases. Event Details: Date: August 3rd (Thursday) 10:00 AM - 12:00 PM (GMT+8) Location: 2nd Floor, Taipei Fuhua International Cultural and Educational Hall Moderator: CEO Wu Zhongxun from DCB Panelists: Katalin Kariko Drew Weissman Pieter Cullis Deputy Chairperson Chen Yi-Chuang from the National Science Council Academician Wang Hui-Jun from Academia Sinica General Manager Hou Jing-Lan from Orient EuroPharma Forum Description: To coincide with the participation of the laureates of the 5th Tang Prize in the award ceremony, the Tang Prize Foundation, along with the Development Center for Biotechnology (DCB), Taiwan Bio Industry Organization (TBIO), and the Industrial Development Bureau, Ministry of Economic Affairs (IBMI), is hosting the 'Tang Prize Taiwan Biotech Forum.' This forum invites experts from Taiwan's industry, government, and academia to have a dialogue with the three biotech and medical award laureates who successfully developed mRNA vaccines for COVID-19, with a focus on the theme 'The Birth of a New Generation of Drugs: mRNA.' The panelists will share their perspectives on the current status and future trends of nucleic acid technology, providing the audience with new insights into this cutting-edge technology and facilitating future collaborations and applications in Taiwan's industry, government, and academia.

Registration Link: https://forms.gle/VhZnRb4Kn6RPLZSA6

For more information about the laureates, please visit : https://www.tang-prize.org/owner.php?cat=11